Effects of Continuous Versus Single Dose Spinal Anesthesia in Octagenerians Undergoing Hip Surgery
Launched by AIN SHAMS UNIVERSITY · Jun 10, 2022
Trial Information
Current as of August 25, 2025
Unknown status
Keywords
ClinConnect Summary
METHODOLOGY:
Patients and Method. Type of Study: Randomized controlled clinical trial. Approval will be obtained from the research ethics committee of Faculty of Medicine; Ain Shams University and a written informed consent will be taken from each patient to participate in the study. Study Setting: Ain-shams University Hospitals, Cairo, Egypt. Study Period: 6 months from approval of medical ethics committee. Sample Size: Based on the study of continuous spinal Anestheisa by Vincent M, Olivier F, and David G, 2006 assuming a rate of hypotension attacks (20% of the baseline blood pressure) o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Either sex
- • 80 to 89 years of age
- • undergoing hip surgery
- Exclusion Criteria:
- • Patient refusal of procedure or participation in the study.
- • Cardiac patients diagnosed with sever Aortic stenosis defined by echo as AVA (aortic valve area) \< 1cm and MPG (mean pressure gradient ) \>40mmHg.
- • Patients with hemodynamic instability.
- • Preexisting infection at the block site.
- • Allergy to local anesthetics.
- • Psychiatric illness.
- • Increased intracranial tension.
- • Patients with coagulopathy problems.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Hany M. Elzahaby, M.D.
Study Director
AinShams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials